FDA Inspection 1201999 — Southern Blood Services Inc

Southern Blood Services Inc — FEI 3002597075

The FDA completed an inspection of Southern Blood Services Inc on April 6, 2023 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 6, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Nashville, TN (United States)